Diverse Biotech is a biopharmaceutical research company committed to discovering and developing novel therapies from its proprietary conjugate drug synthesis platform. It develops therapeutics utilizing cannabinoids, such as cannabidiol (CBD) as core components, which are then combined through conjugate chemistry with other medicines to create new chemical entities. The company focuses on oncologic disorders.